Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.22M Sell
37,054
-451
-1% -$37K 1.6% 14
2019
Q3
$3.01M Sell
37,505
-7,578
-17% -$607K 1.59% 14
2019
Q2
$3.61M Hold
45,083
1.72% 12
2019
Q1
$3.58M Sell
45,083
-6,156
-12% -$460K 1.84% 12
2018
Q4
$3.74M Buy
51,239
+9,176
+22% +$648K 2.07% 9
2018
Q3
$2.85M Buy
42,063
+8,553
+26% +$545K 1.61% 14
2018
Q2
$1.94M Sell
33,510
-209
-0.6% -$11.8K 1.33% 18
2018
Q1
$1.75M Buy
33,719
+5,240
+18% +$283K 1.36% 20
2017
Q4
$1.53M Sell
28,479
-39,101
-58% -$2.17M 1.19% 29
2017
Q3
$4.13M Sell
67,580
-105
-0.2% -$6.37K 3.21% 6
2017
Q2
$4.14M Hold
67,685
3.31% 6
2017
Q1
$4.1M Buy
67,685
+8,733
+15% +$530K 3.67% 6
2016
Q4
$3.31M Hold
58,952
3.35% 8
2016
Q3
$3.51M Sell
58,952
-419
-0.7% -$24.5K 3.57% 6
2016
Q2
$3.26M Sell
59,371
-1,048
-2% -$55.8K 3.43% 6
2016
Q1
$3.05M Buy
60,419
+419
+0.7% +$20.5K 3.15% 7
2015
Q4
$3.02M Buy
60,000
+1,782
+3% +$89.8K 3.26% 8
2015
Q3
$2.74M Buy
58,218
+32,278
+124% +$1.71M 3.23% 9
2015
Q2
$1.41M Hold
25,940
1.38% 25
2015
Q1
$1.42M Hold
25,940
1.36% 24
2014
Q4
$1.41M Hold
25,940
1.28% 24
2014
Q3
$1.47M Hold
25,940
1.35% 22
2014
Q2
$1.43M Hold
25,940
1.29% 22
2014
Q1
$1.41M Hold
25,940
1.25% 22
2013
Q4
$1.24M Hold
25,940
1.1% 24
2013
Q3
$1.18M Hold
25,940
0.98% 25
2013
Q2
$1.15M Buy
+25,940
New +$1.16M 0.98% 26

Other funds holding MRK

Lau Associates's MRK Position: Q4 2019 in Review

Lau Associates reduced its Merck (MRK) stake by 1.2% in Q4 2019, selling an estimated $37K and leaving 37,054 shares worth $3.22M. The position accounts for 1.6% of the portfolio, ranked #14.

Lau Associates first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.14M in Q2 2017. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • Lau Associates held 37,054 shares of Merck worth $3.22M as of Q4 2019.
  • Lau Associates sold 451 Merck shares in Q4 2019, an estimated $37K.
  • Merck made up 1.6% of Lau Associates's portfolio in Q4 2019, its #14 holding.
  • Lau Associates first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
  • Lau Associates's Merck position peaked at $4.14M in Q2 2017.
  • 2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.